| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |